Literature DB >> 24690274

The association between plasma gelsolin level and prognosis of burn patients.

Li Xianhui1, Li Pinglian2, Wang Xiaojuan1, Chen Wei1, Yang Yong1, Ran Feng1, Sun Peng1, Xue Gang3.   

Abstract

OBJECTIVE: To observe the change in plasma gelsolin levels among burn patients, and explore its impact on patient prognosis.
METHODS: This prospective cohort study includes 98 burn patients with burns ≥30% TBSA, who were admitted to our institution between January 2010 and June 2013. Patients were grouped according to burn sizes, development and severity of sepsis, and survival from sepsis. The plasma gelsolin levels among different groups were compared by repeated measure ANOVA. The relationship between plasma gelsolin levels and the presence of sepsis and prognosis was examined by logistic regression.
RESULTS: The plasma gelsolin levels decreased with increasing burn sizes and increasing sepsis severity, with the lowest gelsolin level observed at 7 days after the burn. The plasma gelsolin concentrations were significantly lower among patients with sepsis than those without (P<0.001), and were lower among those who died after sepsis than those who survived (P<0.001). Logistic regression suggested that plasma gelsolin level was inversely associated with the occurrence of sepsis [OR 0.873 (95%CI 0.693-0.993)] and survival after sepsis [OR 0.939 (95%CI 0.859-0.992)]. DISCUSSION: Plasma gelsolin levels decrease after burn. The level is significantly lower among those with large burns and those with combined sepsis. Plasma gelsolin levels can be used to predict the prognosis of burn patients.
Copyright © 2014 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Burn; Plasma gelsolin levels; Prognosis; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 24690274     DOI: 10.1016/j.burns.2014.02.020

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  5 in total

1.  Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.

Authors:  John Audley; Emily F Gliniewicz; Kol A Zarember; Hanna S Hong; Gal Wald; Douglas B Kuhns; Elizabeth Kang; Harry L Malech; Anthony F Suffredini; Robert J Noveck; Mark J Dinubile; Susan L Levinson; Thomas P Stossel; John I Gallin
Journal:  Inflammation       Date:  2020-09-04       Impact factor: 4.092

2.  Quantitative proteomic analysis of serum from pregnant women carrying a fetus with conotruncal heart defect using isobaric tags for relative and absolute quantitation (iTRAQ) labeling.

Authors:  Ying Zhang; Yuan Kang; Qiongjie Zhou; Jizi Zhou; Huijun Wang; Hong Jin; Xiaohui Liu; Duan Ma; Xiaotian Li
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

3.  Recombinant Human Plasma Gelsolin Stimulates Phagocytosis while Diminishing Excessive Inflammatory Responses in Mice with Pseudomonas aeruginosa Sepsis.

Authors:  Ewelina Piktel; Urszula Wnorowska; Mateusz Cieśluk; Piotr Deptuła; Suhanya V Prasad; Grzegorz Król; Bonita Durnaś; Andrzej Namiot; Karolina H Markiewicz; Katarzyna Niemirowicz-Laskowska; Agnieszka Z Wilczewska; Paul A Janmey; Joanna Reszeć; Robert Bucki
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

Review 4.  Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target.

Authors:  Ewelina Piktel; Ilya Levental; Bonita Durnaś; Paul A Janmey; Robert Bucki
Journal:  Int J Mol Sci       Date:  2018-08-25       Impact factor: 5.923

5.  Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure.

Authors:  Freja Stæhr Holm; Pradeesh Sivapalan; Niels Seersholm; Theis Skovsgaard Itenov; Per Hjort Christensen; Jens-Ulrik Stæhr Jensen
Journal:  Shock       Date:  2019-09       Impact factor: 3.454

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.